Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...
Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusi...
PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscop...
Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acq...
Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...
Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreem...
Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...
US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...
Astellas Pharma Inc. and Seattle Genetics, Inc. have announced that the U.S. Food and Drug Administration (FD...
Japan based PHC Corporation has announced it was taking a stake in KAKEHASHI Inc., based on a share purchase agreement w...
Japan Agency for Medical Research and Development (AMED) and Singapore’s Agency for Science, Technology and Resear...
Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...
PENTAX Medical, a division of the HOYA Group which is a global med-tech company based in Tokyo, Japan, has cleared CE ma...
AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...
Japan based Eisai Co., Ltd. has had a groundbreaking ceremony for a major renovation of its Tsukuba Research Laboratorie...
FUJIFILM Toyama Chemical has announced the construction completion of a new manufacturing facility (facil...
Japan based Solasia Pharma K.K. has announced that it has entered into an exclusive license agreement with Maruho Co., L...
